Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Boehringer Ingelheim microParts (Boehringer) has opened module 2 of its new atomisation factory, a four-storey production facility at the Dortmund Technology Park, with an investment of about €70m.
Subscribe to our email newsletter
Boehringer, with its new production facility, is doubling its annual production capacity to 20 million inhalation devices (Respimat Soft Mist Inhaler).
The expansion also involves the creation of new, modern workstations, as Respimat production will require up to 150 additional employees at full capacity.
The Respimat Soft Mist Inhaler from Boehringer Ingelheim is an atomiser that delivers medication for the treatment of respiratory diseases.
Boehringer said that two-thirds of the investment volume was spent on the technical equipment of the building and the production systems.